BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 8709216)

  • 21. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family.
    Pan J; McEver RP
    J Biol Chem; 1995 Sep; 270(39):23077-83. PubMed ID: 7559449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation.
    Kunsch C; Ruben SM; Rosen CA
    Mol Cell Biol; 1992 Oct; 12(10):4412-21. PubMed ID: 1406630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element.
    Chen NN; Chang CF; Gallia GL; Kerr DA; Johnson EM; Krachmarov CP; Barr SM; Frisque RJ; Bollag B; Khalili K
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1087-91. PubMed ID: 7862639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits.
    Brown AM; Linhoff MW; Stein B; Wright KL; Baldwin AS; Basta PV; Ting JP
    Mol Cell Biol; 1994 May; 14(5):2926-35. PubMed ID: 8164652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-talk between transcription factors NF-kappa B and C/EBP in the transcriptional regulation of genes.
    Xia C; Cheshire JK; Patel H; Woo P
    Int J Biochem Cell Biol; 1997 Dec; 29(12):1525-39. PubMed ID: 9570146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
    Matsusaka T; Fujikawa K; Nishio Y; Mukaida N; Matsushima K; Kishimoto T; Akira S
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10193-7. PubMed ID: 8234276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synergism between transcription factors NF-IL6 and NF-kappa B in IL-6 gene regulation].
    Fujikawa K
    Hokkaido Igaku Zasshi; 1992 Jul; 67(4):563-74. PubMed ID: 1427600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
    Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
    Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins.
    John S; Reeves RB; Lin JX; Child R; Leiden JM; Thompson CB; Leonard WJ
    Mol Cell Biol; 1995 Mar; 15(3):1786-96. PubMed ID: 7862168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators.
    Schmitz ML; Stelzer G; Altmann H; Meisterernst M; Baeuerle PA
    J Biol Chem; 1995 Mar; 270(13):7219-26. PubMed ID: 7706261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
    Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
    J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity.
    Gribaudo G; Ravaglia S; Gaboli M; Gariglio M; Cavallo R; Landolfo S
    Virology; 1995 Aug; 211(1):251-60. PubMed ID: 7645218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.
    La Rosa FA; Pierce JW; Sonenshein GE
    Mol Cell Biol; 1994 Feb; 14(2):1039-44. PubMed ID: 8289784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop.
    Hiscott J; Marois J; Garoufalis J; D'Addario M; Roulston A; Kwan I; Pepin N; Lacoste J; Nguyen H; Bensi G
    Mol Cell Biol; 1993 Oct; 13(10):6231-40. PubMed ID: 8413223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NF-kappa B p65 promoter.
    Ueberla K; Lu Y; Chung E; Haseltine WA
    J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):227-30. PubMed ID: 8450395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A NF-kappaB p65 subunit is indispensable for activating manganese superoxide: dismutase gene transcription mediated by tumor necrosis factor-alpha.
    Maehara K; Hasegawa T; Isobe KI
    J Cell Biochem; 2000 Apr; 77(3):474-86. PubMed ID: 10760955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.
    Stein B; Baldwin AS
    Mol Cell Biol; 1993 Nov; 13(11):7191-8. PubMed ID: 8413306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
    Scheinman RI; Beg AA; Baldwin AS
    Mol Cell Biol; 1993 Oct; 13(10):6089-101. PubMed ID: 8413211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concerted participation of NF-kappa B and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver.
    Ray A; Hannink M; Ray BK
    J Biol Chem; 1995 Mar; 270(13):7365-74. PubMed ID: 7706280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.